ARMR Sciences Tests 1st Human Fentanyl Vaccine, Showing Promise in Early Trial

3 articles · Updated · NBC News · Jun 17

ARMR Sciences said Wednesday its experimental fentanyl vaccine showed promising results in an early-stage human clinical trial.
The study marks the first time a fentanyl vaccine has been tested in humans, making the readout an early milestone for overdose-prevention research.
The vaccine still must prove effective in larger trials before it can be considered a viable tool against fentanyl deaths.
Experts say success in later-stage testing could deliver a major breakthrough in the U.S. fight against the opioid epidemic.

Sources

NBC News21h ago

ARMR Sciences' Experimental Fentanyl Vaccine Shows Promise in Early-Stage Human Trial

YouTube21h ago

Experimental fentanyl vaccine showed promise in an early-stage trial

IBTimes UK21h ago

Scientists Say a New Vaccine Could Leave Fentanyl Users Feeling Nothing and Unable to Overdose | IBTimes UK

5 Sources

Can a fentanyl-only vaccine outpace the rapidly evolving synthetic drug market?

Is a 'tech fix' vaccine the answer to a crisis rooted in human despair and addiction?

Human Trials Begin for Groundbreaking Fentanyl Vaccine: A New Front in Overdose Prevention Amid U.S. Opioid Crisis

Overview

Amidst the ongoing opioid crisis and the relentless fentanyl epidemic, ARMR Sciences has launched Phase 1/2 human clinical trials for a novel fentanyl vaccine in the Netherlands. This vaccine is urgently needed, as fentanyl remains the leading cause of overdose deaths in the United States. The vaccine works by training the body’s immune system to neutralize fentanyl, so vaccinated individuals would not experience a high or a fatal overdose. Unlike current treatments, this proactive approach does not require carrying emergency medication and could change how overdoses are prevented, offering new hope in combating this public health emergency.

...